Gracell Biotechnologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Gracell Biotechnologies generated cash of -$3,307,096,051, which is less than the previous year. Cash used in financing activities reached the amount of $228,335,492 last year. Net change in cash is therefore -$2,565,115,332.
Cash Flow
| 2018 | -61.85M | -113.35M | 138.69M |
|---|---|---|---|
| 2019 | -135.39M | 41.36M | 394.79M |
| 2020 | -198.14M | -93.94M | 756.46M |
| 2021 | -304.55M | -41.61M | 1.45B |
| 2022 | -3.30B | -331.17M | 228.33M |
GRCL Cash Flow Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Cash at beginning of period | 12.53B | 754.30M | 312.05M | 11.89M | 48.40M |
Operating activities | |||||
Net income | -4.16B | -451.75M | -211.9M | -138.66M | -60.79M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 531.08M | 60.26M | 21.58M | 5.12M | 2.99M |
Stock-based compensation expense | 165.14M | 60.38M | 0 | 0 | 0 |
| Deferred income tax benefit | 165.14M | 60.38M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -3.30B | -304.55M | -198.14M | -135.39M | -61.85M |
Investing activities | |||||
Purchases Of Investments | -1.78B | -10M | -28.05M | -80.2M | -335M |
Investments In Property Plant And Equipment | -331.55M | -56.74M | -79.4M | -56.43M | -11.35M |
Acquisitions Net | 1.78B | 10M | 28.05M | -97.8K | 0 |
Cash generated by investing activities | -331.17M | -41.61M | -93.94M | 41.36M | -113.35M |
Financing activities | |||||
Common Stock Issued | 0 | 1.44B | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -44.70M | 0 |
Repayments of term debt | 0 | -51.29M | -138.81M | 0 | -10M |
Cash used in financing activities | 228.33M | 1.45B | 756.46M | 394.79M | 138.69M |
Net Change In Cash | -2.56B | 1.07B | 442.25M | 300.16M | -36.51M |
Cash at end of period | 9.96B | 1.82B | 754.30M | 312.05M | 11.89M |
| Data source | Data source | Data source |